We support clinics with sensitive, accessible cognitive testing.
Cognitive testing for Your modern medical practice
Traditional cognitive tests (like the MMSE, MoCA or ACE-III) aren't fit for purpose. They miss subtle early changes in brain function, rely on crude pass/fail scoring, and can’t track subtle progress over time. This lack of sensitivity means that diagnosis comes too late, and patient care is impacted.
PREMAZ is a 10-minute digital cognitive assessment tool done on an iPad or tablet. It can be completed fully remotely or in a clinic, is scalable and incredibly sensitive to early cognitive decline.
How PREMAZ is different:
Hear from our founder:
How Our System works
Flexible for Any Size Clinic
PREMAZ scales with you, whether you run a boutique medical practice or a multi-location clinical network. From 10 patients a month to hundreds, we can support a range of different organisations.
Low Barrier to Entry
Start screening patients within weeks. PREMAZ requires no special setup or training, just an iPad and a Wi-Fi connection. Our test integrates easily into your existing clinical workflows.
Scales With You
As your clinic grows, PREMAZ grows with it. Transparent, usage-based pricing means you pay only for what you use: no hidden costs, no steep licensing fees.
Accessible Science
Our test was built with accessibility at its core. Our test is designed to be used by age 18-85, either fully remotely or independently or facilitated by a clinician.
Value Beyond the Test
Our platform generates an insightful report on your patient's cognitive function, and allows you to easily monitor changes over time.
Simple workflow. Powerful outcomes.
Step 1 — Setup
Step 2 — Baseline
Step 3 — Re-test
Step 4 — Improve
Meet the Team
Dr Julia Cooney
Medical doctor with a master's in biotechnology from Cambridge, Julia is a second time HealthTech founder with 10 years experience working across the clinical and commercial sides of healthcare.
Despite starting her career on track to become a surgeon, Julia pivoted into HealthTech after her time at Cambridge, and now and serves as a medical advisor on several prominent boards.
Her unique expertise straddles tech and medicine, making her well positioned to bring PREMAZ from the research lab into the hands of patients.
Cameron Kirkpatrick
Background in biological sciences before switching to B2B and B2C SaaS sales and digital marketing across healthtech, finance, and enterprise software markets. Brings a strong track record in driving growth and strategic partnerships.
Matt Reynolds
Experienced software architect with 25 years’ experience delivering scalable digital systems across healthcare.
Matt combines technical expertise with understanding of clinical workflows to build secure, compliant, and user-centred health technologies.
Keith Williams
Biotech entrepreneur and technology leader with 30 years' experience in large-scale bioprocessing, pharma, SaaS, and synthetic biology. He has founded, scaled, and exited multiple companies, and brings deep expertise in project delivery, regulatory environments, and commercial strategy. At PREMAZ, Keith advises on regulatory pathways, CRO and pharma market strategy, and scaling the platform for rapid adoption.
Prof Jon Simons
Head of the School of Biological Sciences at Cambridge University, and previous head of the Memory Lab at Cambridge. Professor of cognitive neuroscience at Cambridge, thought leader in cognitive health with 50+ publications.
Dr Ravi Badge
Dr Ravi Badge is an NHS Consultant Orthopaedic Surgeon. A long-standing figure across elite sport, he served on the team supporting athletes at the Paris 2024 Olympics, and is Treasurer of the British Orthopaedic Sports Trauma & Arthroscopy Association (BOSTAA) and Sports Secretary for the British International Doctors Association (BIDA).
Ravi’s research and advocacy include projects on concussion and mild traumatic brain injury in sport, and he frequently advises health and technology initiatives on clinical validation, pathway design and commercial adoption. At PREMAZ, he helps shape strategy at the intersection of early cognitive assessment and contact-sport populations, opening doors with federations, clinicians and research partners.
Dr Alan Thornhill PhD
Experienced published scientist with a demonstrated history of working in the clinical and biotechnology industry. Over 25 years in Clinical Practice, Laboratory management, Medical Diagnostics, Research and Education and Commercial roles in these industries. Served on many professional boards including the UK's fertility regulator (HFEA). Currently CSO for Advance Tests, an Alzheimer's blood biomarker testing company.
Dr Helena Gellersen
Cognitive neuroscientist specializing in memory, ageing, and early Alzheimer’s disease. PhD in Psychology from the University of Cambridge, now a postdoctoral researcher at the German Center for Neurodegenerative Diseases (DZNE) and Cambridge University, where she investigates the preclinical stages of dementia using behavioural, neuroimaging, and digital assessment methods.
Helena is the inventor of the Precision Memory Test and the lead author of multiple peer-reviewed publications demonstrating the test’s sensitivity to early cognitive change. Her broader work focuses on developing novel digital tools to detect Alzheimer’s disease earlier and more accurately.
Join our early adopter pilot program
And shape the future of brain health.
